When evaluating options to buy local immunity regulation Chonluten, laboratory researchers require fully verified purity, precise sequence synthesis, and transparent bulk pricing structures. PX1 Research supplies high-purity Chonluten tripeptide backed by lot-specific analytical documentation for in vitro and preclinical research applications.
When evaluating options to buy local immunity regulation Chonluten, laboratory researchers require fully verified purity, precise sequence synthesis, and transparent bulk pricing structures. PX1 Research supplies high-purity Chonluten tripeptide backed by lot-specific analytical documentation for in vitro and preclinical research applications.
To buy local immunity regulation Chonluten for laboratory research, investigators must balance unit pricing against rigorous quality verification. Chonluten price varies based on peptide purity, sequence fidelity, lot-specific analytical testing, and order volume. PX1 Research provides USA-manufactured, RP-HPLC and mass spectrometry-verified Chonluten with low endotoxin levels, offering tiered institutional pricing and same-day dispatch from California and Arizona facilities for qualified research facilities.
Evaluating research peptide pricing requires looking beyond nominal cost-per-milligram figures. Substandard synthetic methods often leave trifluoroacetic acid (TFA) residues, truncated peptide fragments, or bacterial endotoxins that invalidate cell culture and mucosal tissue assays. Securing authentic, high-purity material from an ISO 17025-accredited laboratory partner ensures experimental reproducibility across local immunity, bronchial epithelial, and bioregulatory research models.
Chonluten (synthesized as L-glutamyl-L-aspartyl-glycine, sequence: H-Glu-Asp-Gly-OH or EDG) is a synthetic short-chain peptide belonging to the class of Khavinson peptide bioregulators. To understand its chemical behavior in controlled assays, researchers examine its specific tripeptide sequence and side-chain carboxyl groups, which confer specific ionic binding properties at physiological pH.
With a molecular weight of approximately 305.24 g/mol, the EDG tripeptide interacts directly with nuclear histone proteins and specific genomic regulatory regions. Preclinical studies suggest that short peptide sequences like EDG penetrate cellular and nuclear membranes without requiring specialized transporter systems, permitting direct interaction with chromatin structures in respiratory epithelial and immunocompetent cell lines. Detailed chemical characteristics can be explored across our broader all peptides catalog.
In vitro assays demonstrate that Chonluten plays a target-specific role in modulating local immunity, particularly within bronchial and pulmonary mucosal tissue models. Research indicates that the EDG tripeptide influences the gene expression of proinflammatory cytokines, helping to stabilize local cellular responses under induced oxidative or toxic stress.
In vitro data indicate that exposure to Chonluten modulates the synthesis of interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) in damaged epithelial cells. By dampening hyper-reactive inflammatory signaling while supporting baseline cellular repair, the peptide serves as a valuable molecular tool for studying tissue-level homeostatic regulation and mucosal defense mechanisms. Investigators can review broader regulatory peptide models within the PX1 research hub.
A primary focus of research surrounding Chonluten centers on its activity in pulmonary tissue cultures and organoid models. Preclinical studies suggest that EDG restores functional protein expression in ciliated epithelial cells following exposure to environmental toxicants, endotoxins, or viral mimetics.
Specifically, rodent and cell culture models reveal that Chonluten application increases the transcription of genes regulating mucociliary clearance and structural integrity, such as cytokeratins and tight junction proteins. These findings make the compound a prime candidate for laboratories investigating inflammatory lung conditions, chronic tissue remodeling, and localized pulmonary immune responses.
When designing comparative assays for local immunity and tissue protection, researchers frequently evaluate Chonluten alongside other short-chain peptide bioregulators targeting distinct organ systems.
For instance, while Chonluten specifically targets respiratory epithelial gene expression and local pulmonary immunity, Bronchogen (Ala-Glu-Asp-Leu) is studied for structural airway remodeling, and Thymogen (Glu-Trp) targets systemic T-cell maturation and general immune signaling. Similarly, Vilon (Lys-Glu) is investigated for chromatin condensation changes and systemic immunomodulation. Understanding these functional distinctions enables laboratories to select the precise peptide or combination for multi-target organ culture protocols, as detailed in our guide on Khavinson peptides overview.
To ensure valid experimental outcomes when buying Chonluten for local immunity regulation assays, research institutions must enforce strict quality standards. Low-grade peptides contaminated with lipopolysaccharides (LPS/endotoxins) can trigger non-specific inflammatory cascades in cell culture, entirely confounding local immunity data.
PX1 Research ensures that every batch of Chonluten undergoes rigorous testing. Every lot is verified by independent, third-party ISO 17025 laboratories using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chemical purity (>98%) and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for exact sequence identity. Furthermore, quantitative Chromogenic Reagent Endotoxin Assays ensure endotoxin levels remain below strictly defined thresholds (<0.01 EU/μg).
The market price of research-grade Chonluten is determined by several manufacturing and analytical control steps. High-yield solid-phase peptide synthesis (SPPS), multi-stage liquid chromatography purification, and sub-ambient lyophilization contribute directly to the final cost of reliable research material.
Procurement officers and principal investigators should avoid unverified vendors offering low-cost material without lot-matched Certificates of Analysis (COAs). Substandard synthesis often results in racemized amino acid residues or residual heavy metals. PX1 Research offers tier-structured pricing for institutional labs and high-throughput screening applications, backed by transparent quality verification. Qualified institutions can establish dedicated supply channels via our wholesale lab accounts program.
Proper reconstitution is critical to maintain the chemical stability and biological activity of lyophilized Chonluten in experimental settings. The peptide is highly soluble in aqueous buffer systems due to the polar hydrophilic side chains of its glutamic acid and aspartic acid residues.
For sterile cell culture applications, lyophilized Chonluten should be reconstituted using sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS, pH 7.4), or sterile water for injection under a laminar flow hood. After adding the solvent along the internal glass vial wall, gentle swirled agitation should be used—vigorous vortexing should be avoided to prevent mechanical shearing or aggregation. Reconstituted stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent degradation caused by repeated freeze-thaw cycles.
Lyophilized Chonluten powder demonstrates long-term stability when stored at -20°C or -80°C in a desiccated environment protected from light exposure. Under these conditions, the un-reconstituted peptide retains structural integrity for up to 24 months.
Once reconstituted in sterile aqueous buffer, stock solutions should be stored at 2°C to 8°C for short-term use (up to 7 days) or frozen at -80°C for extended research periods. Laboratory personnel should utilize low-protein-binding polypropylene tubes to minimize non-specific peptide adsorption to container surfaces during serial dilutions.
PX1 Research operates strictly as a USA-based supplier of high-purity research compounds. All products are synthesized in cGMP-compliant facilities and tested by third-party laboratories to guarantee batch-to-batch consistency for the scientific community.
To prevent research downtime, PX1 maintains robust inventory reserves in centralized logistics hubs in California and Arizona, offering same-day shipping on orders placed Monday through Friday before cut-off times. Every shipment includes comprehensive documentation, including lot-specific COAs, HPLC chromatograms, and mass spectra analysis, ensuring complete traceability from synthesis to benchtop.
What is the sequence and chemical structure of Chonluten?
Chonluten is a synthetic tripeptide consisting of the amino acid sequence L-glutamyl-L-aspartyl-glycine (Glu-Asp-Gly or EDG), with a molecular weight of approximately 305.24 g/mol.
What preclinical models is Chonluten used for?
Chonluten is primarily used in preclinical and in vitro models studying bronchial epithelial gene expression, local respiratory immunity regulation, inflammatory cytokine modulation, and mucosal barrier repair.
How does PX1 Research verify the purity of Chonluten?
PX1 Research verifies Chonluten purity through third-party ISO 17025 laboratory testing utilizing RP-HPLC for chemical purity (>98%), Mass Spectrometry for molecular identity, and LAL assays for endotoxin verification.
Why does research Chonluten pricing vary between suppliers?
Pricing variations reflect differences in synthesis precision, multi-stage chromatographic purification, third-party analytical verification, endotoxin testing, and regulatory compliance. Low-cost sources frequently lack lot-specific COAs and purity controls.
What solvent is recommended for reconstituting Chonluten in cell culture assays?
Sterile Phosphate-Buffered Saline (PBS, pH 7.4) or sterile water for injection is recommended for cell culture assays. Stock solutions should be prepared in a laminar flow hood using aseptic technique.
How should reconstituted Chonluten be stored in the lab?
Reconstituted stock solutions should be aliquoted into low-binding polypropylene tubes and stored at -80°C for long-term stability or 2°C to 8°C for immediate use within 7 days, avoiding freeze-thaw cycles.
What are the endotoxin limits for PX1 Research Chonluten?
PX1 Research Chonluten is batch-tested to ensure endotoxin levels remain below 0.01 EU/μg, preventing non-specific immune activation in delicate cell culture and organoid assays.
Can institutions buy Chonluten in bulk for large screening projects?
Yes, PX1 Research provides institutional tier pricing and bulk procurement options for research laboratories through our dedicated wholesale account portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.